Prescription medication · HMG-CoA Reductase Inhibitor (Statin)
rosuvastatin
Also sold as Crestor. Rosuvastatin is used to lower bad cholesterol (LDL) in adults and children.
Data updated 2026-05-15
- 194,743
- FDA reportsHeavily reported
- 21
- InteractionsSeveral interactions
- 99% less
- Generic vs brandHuge savings
- 2
- Recall records
What the data shows
rosuvastatin (Crestor) is a prescription HMG-CoA Reductase Inhibitor (Statin), more reported than roughly 9 in 10 tracked drugs (194,743 FDA reports), whose generic costs a fraction of the brand (about 99% less).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
rosuvastatin (Crestor) is a prescription HMG-CoA Reductase Inhibitor (Statin). Rosuvastatin is used to lower bad cholesterol (LDL) in adults and children.
Rosuvastatin is a drug that lowers cholesterol. It helps to reduce the risk of heart problems and stroke.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$8.86/unit
Generic Price
$0.04/unit
Generic Savings
99%
Generic Available
Yes (18 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
NADAC price trail: ROSUVASTATIN CALCIUM 10 MG TAB
Same CMS presentation as the headline generic unit price above (2 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: -3.9% vs prior release.
| Effective | NADAC / unit | vs prior | NDCs |
|---|---|---|---|
| April 17, 2024 | $0.0412/EA | - | 1 |
| December 18, 2024 | $0.0396/EA | -3.9% | 42 |
What it does
Rosuvastatin is used to lower bad cholesterol (LDL) in adults and children.
Common side effects
Headache, Nausea, Muscle pain
Key warnings
Rosuvastatin can cause muscle problems, including muscle pain, tenderness, or weakness.
The sections below are summarized in plain English from rosuvastatin's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Rosuvastatin belongs to a class of drugs called statins. It works by blocking a substance your body needs to make cholesterol. This helps to lower your cholesterol levels.
Side Effects (from patient reports)
Based on 194,743 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for rosuvastatin, by number of reports
- Fatigue
Fatigue
11,700 reports
- Nausea
Nausea
10,039 reports
- Dyspnoea
Dyspnoea
9,208 reports
- Diarrhoea
Diarrhoea
9,198 reports
- Myalgia
Myalgia
8,784 reports
- Pain
Pain
8,417 reports
- Headache
Headache
7,796 reports
- Dizziness
Dizziness
7,718 reports
- Arthralgia
Arthralgia
7,255 reports
- Asthenia
Asthenia
7,203 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for rosuvastatin each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where rosuvastatin sits
rosuvastatin has more FDA adverse-event reports than 94% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is rosuvastatin; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 194,743 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
194,743
Reports Mentioning Death
11,716
6.0% of reports — not proof of cause
Hospitalization Reports
60,611
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | FATIGUE | 11,700 |
| 2 | NAUSEA | 10,039 |
| 4 | DYSPNOEA | 9,208 |
| 5 | DIARRHOEA | 9,198 |
| 6 | MYALGIA | 8,784 |
| 8 | PAIN | 8,417 |
| 9 | HEADACHE | 7,796 |
| 10 | DIZZINESS | 7,718 |
| 11 | ARTHRALGIA | 7,255 |
| 12 | ASTHENIA | 7,203 |
| 13 | PAIN IN EXTREMITY | 6,768 |
| 14 | MALAISE | 6,483 |
| 15 | FALL | 6,006 |
| 16 | VOMITING | 5,828 |
| 17 | ACUTE KIDNEY INJURY | 5,250 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Rosuvastatin can cause muscle problems, including muscle pain, tenderness, or weakness. Tell your doctor right away if you have these symptoms, especially if you also have a fever or feel sick. Rosuvastatin can also cause liver problems. Your doctor may do blood tests to check your liver before and during treatment.
Known Drug Interactions
Intervention: Sofosbuvir/velpatasvir/voxilaprevir Ledipasvir/sofosbuvir Avoid concomitant use with rosuvastatin. Simeprevir Dasabuvir/ombitasvir/paritaprevir/ritonavir Elbasvir/grazoprevir Sofosbuvir/velpatasvir Glecaprevir/pibrentasvir Atazanavir/ritonavir Lopinavir/ritonavir Initiate with rosuvastatin 5 mg once daily, and do not exceed a dose of rosuvastatin 10 mg once daily.
Mechanism: This hepatitis C medication can increase the amount of rosuvastatin that stays in your blood.
Simeprevir Dasabuvir/ombitasvir/paritaprevir/ritonavir Elbasvir/grazoprevir Sofosbuvir/velpatasvir Glecaprevir/pibrentasvir Atazanavir/ritonavir Lopinavir/ritonavir Initiate with rosuvastatin 5 mg once daily, and do not exceed a dose of rosuvastatin 10 mg once daily.
Mechanism: These drugs can cause rosuvastatin levels to rise in your body, which may increase the risk of side effects.
Febuxostat Clinical Impact: Febuxostat increased rosuvastatin exposure more than 1.9-fold. Intervention: In patients taking febuxostat, do not exceed a dose of rosuvastatin 20 mg once daily.
Mechanism: Febuxostat slows down how your body gets rid of rosuvastatin, causing the medicine to build up in your blood. This increase can make side effects more likely.
Table 5: Drug Interactions that Increase the Risk of Myopathy and Rhabdomyolysis with Rosuvastatin Cyclosporine Clinical Impact: Cyclosporine increased rosuvastatin exposure 7-fold. The risk of myopathy and rhabdomyolysis is increased with concomitant use of cyclosporine or gemfibrozil with rosuvastatin.
Mechanism: Cyclosporine stops your body from clearing rosuvastatin, leading to much higher levels of the drug in your blood. This increase makes it much more likely that you will experience severe muscle damage.
Intervention: Sofosbuvir/velpatasvir/voxilaprevir Ledipasvir/sofosbuvir Avoid concomitant use with rosuvastatin.
Mechanism: These medications can raise the levels of rosuvastatin in your blood to unsafe levels. This increases your risk of developing serious muscle problems.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I take rosuvastatin with other medications?
How long will I need to take rosuvastatin?
Can I drink alcohol while taking rosuvastatin?
What should I do if I experience muscle pain while taking rosuvastatin?
Will I need blood tests while taking rosuvastatin?
Can I stop taking rosuvastatin if my cholesterol levels are good?
Does rosuvastatin have any effect on diabetes?
Are there any foods I should avoid while taking rosuvastatin?
Can rosuvastatin cause weight gain?
Is it safe for elderly people to take rosuvastatin?
What are the common side effects of rosuvastatin?
Does rosuvastatin interact with other medications?
What drug class is rosuvastatin?
Is there a generic version of rosuvastatin?
What pregnancy or breastfeeding source fields are listed for rosuvastatin?
Has rosuvastatin been recalled?
Active Recalls
Out of specification for dissolution.
AvKARE
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Preferred Pharmaceuticals, Inc.
Related Medications in HMG-CoA Reductase Inhibitor (Statin)
Other drugs grouped near rosuvastatin - same-class peers and common alternatives.
alirocumab
Praluent
Praluent is a medicine that can lower cholesterol.
Compare with rosuvastatin →
atorvastatin
Lipitor
Atorvastatin is a drug that lowers cholesterol and reduces the risk of heart problems and stroke.
Compare with rosuvastatin →
bempedoic acid
Nexletol
Compare with rosuvastatin →
bempedoic acid/ezetimibe
Nexlizet
Nexlizet is a combination medicine that helps lower cholesterol.
Compare with rosuvastatin →
cholestyramine
Questran
Cholestyramine is a medicine that helps lower high cholesterol levels in your blood.
Compare with rosuvastatin →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for rosuvastatin: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 194,743.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 6.02%.
- baloxavir marboxil Δ 0.01 pts · 2,164 reports · Endonuclease Inhibitor (Antiviral) 6.01%death share
- chlorthalidone Δ 0.07 pts · 11,035 reports · Thiazide-Like Diuretic 5.94%death share
- zonisamide Δ 0.10 pts · 14,210 reports · Anticonvulsant (Sulfonamide) 6.12%death share
- dicyclomine Δ 0.11 pts · 13,367 reports · Anticholinergic / Antispasmodic 5.91%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on rosuvastatin
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for rosuvastatin
The FDA label for rosuvastatin (sold under brand names such as Crestor) classifies it as a prescription-only medication in the HMG-CoA Reductase Inhibitor (Statin) class. Rosuvastatin is used to lower bad cholesterol (LDL) in adults and children. Official labeling lists 5 commonly reported side effects, including Headache, Nausea, Muscle pain.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 194,743 voluntary reports. The database also lists 21 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.04 versus $8.86 for the brand - a 99% generic savings.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 2 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: November 26, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages